LYON, France, Sept. 11, 2008 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today its schedule to participate in national and local patient outreach efforts during prostate cancer awareness month. The Company hopes to increase its visibility among the prostate cancer patient and physician community as the leader in non-invasive therapeutic ultrasound. EDAP’s presence is also aimed at accelerating recruitment efforts for patient enrollment in the U.S. ENLIGHT trial.
